A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study-Reference-Cited by-同舟云学术

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

Published:2017-02-02 Issue:3 Volume:176 Page:624-633
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

de Vries A.C.Q.¹,Thio H.B.²,de Kort W.J.A.³,Opmeer B.C.⁴,van der Stok H.M.¹,de Jong E.M.G.J.⁵,Horvath B.⁶,Busschbach J.J.V.⁷,Nijsten T.E.C.²,Spuls Ph.I.¹

Affiliation:

1. Department of Dermatology; Academic Medical Center; Meibergdreef 9 1105 AZ Amsterdam the Netherlands

2. Department of Dermatology; Erasmus Medical Center; 3015 CA Rotterdam the Netherlands

3. Department of Dermatology; Amphia Hospital; Molengracht 21 4818 CK Breda the Netherlands

4. Clinical Research Unit; Academic Medical Center; Meibergdreef 9 1105 AZ Amsterdam the Netherlands

5. Department of Dermatology; UMC St Radboud; René Descartesdreef 1 6525 GL Nijmegen the Netherlands

6. Department of Dermatology; UMC Groningen; Hanzeplein 1 9713 GZ Groningen the Netherlands

7. Medical Psychology and Psychotherapy Section; Erasmus Medical Center; 3015 CA Rotterdam the Netherlands

Funder

The Netherlands Organization for Scientific Research-Medical Sciences

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14867/fullpdf

Reference39 articles.

1. Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis;Gottlieb;Br J Dermatol,2011

2. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis;Griffiths;N Engl J Med,2010

3. A phase 2 trial of guselkumab versus adalimumab for plaque psoriasis;Gordon;N Engl J Med,2015

4. The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication;Schott;Dtsch Arztebl Int,2010

5. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials;Schulz;BMC Med,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-Analysis;Journal of Clinical Medicine;2024-08-29

2. Head-to-Head-Studien bei Psoriasis und Psoriasisarthritis;Zeitschrift für Rheumatologie;2024-08-14

3. Short Term Efficacy of Biological Treatment for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis;2024-08-05

4. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets;Frontiers in Immunology;2024-01-04

5. Signaling pathways and targeted therapies for psoriasis;Signal Transduction and Targeted Therapy;2023-11-27